Efficacy and safety in Phase II trials.
Black
D M
DM
Parke-Davis Pharmaceutical Research, Division of Warner Lambert, Ann Arbor, Michigan, USA.
D000818:Animals; D017322:Clinical Trials, Phase II as Topic / Q000379:methods*; D004341:Drug Evaluation / Q000379:methods*; D015507:Drugs, Investigational; D005260:Female; D006801:Humans; D008297:Male; D012449:Safety
D015507:Drugs, Investigational